Log in to search using one of your social media accounts:

 

Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS? Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS?
For patients with oropharyngeal squamous cell carcinoma (OPSCC) receiving transoral robotic surgery (TORS), adjuvant radiotherapy or chemoradiotherapy (CRT) should be avoided if possible, according to a long-term functional and quality-of-life (QOL) outcomes study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 6, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Risk for HPV-Related Throat Cancer Is'Reassuringly' Low Risk for HPV-Related Throat Cancer Is'Reassuringly' Low
Despite recent reports about the incidence of HPV infection in this area of the body, HPV-associated oropharyngeal cancer remains uncommon, a new study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Better Outcomes With Transoroal Robotic Surgery Alone in OPSCC
Significantly quicker improvement in postoperative dysphagia in oropharyngeal cancer TORS - only group (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 27, 2017 Category: Cancer & Oncology Tags: Oncology, ENT, Radiology, Surgery, Journal, Source Type: news

Men who perform oral sex on women 'more at risk of mouth and throat cancers'
Conclusion This study uses a large amount of national data to give us an idea about which groups of people have the greatest risk of carrying potentially cancer-causing oral HPV . But while oral HPV may increase people's risk of mouth and throat cancers, the actual number who would go on to develop cancer is extremely small. This study has limitations, which are worth bearing in mind: It only looked at whether people had oral HPV at a single point in time. This makes it difficult to know at what point they became infected and how much this could be down to other risk factors such as smoking, oral sex and number of partne...
Source: NHS News Feed - October 20, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Reduced-Dose RT Controls HPV+ Oropharynx Cancer (CME/CE)
(MedPage Today) -- Dramatic decline in toxicity (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 26, 2017 Category: Consumer Health News Source Type: news

David Sher on the Updated ASTRO Guidelines for Oropharyngeal Cancer
In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer. (Source: CancerNetwork)
Source: CancerNetwork - September 15, 2017 Category: Cancer & Oncology Authors: David J. Sher, MD, MPH Tags: Head & Neck Cancer Oncology Journal Q Source Type: news

Hefty Price for HPV+ Oropharyngeal Cancer (CME/CE)
(MedPage Today) -- Healthcare costs approaching $140,000 for 2 years of care (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 25, 2017 Category: American Health Source Type: news

Average cost of first 2 years of oropharyngeal cancer treatment in Texas is $139,749
(American Association for Cancer Research) In Texas, the average cost for the first two years of health care after a diagnosis of oropharyngeal cancer was $139,749. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news

Newly developed nomograms provide accurate predictions for patients with oropharyngeal cancer
(NRG Oncology) NRG Oncology researchers recently developed and validated a nomogram that can predict 2-year and 5-year overall survival (OS) and progression-free survival (PFS) for patients with local-regionally advanced oropharyngeal squamous cell carcinoma (OPSCC) treated primarily with radiation-based therapy. This nomogram was developed with data from clinical trials NRG Oncology/RTOG 0129 and 0522. Results were published online in the Journal of Clinical Oncology on Aug. 4, 2017. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 21, 2017 Category: Cancer & Oncology Source Type: news

Oropharyngeal Cancer Treatment
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 1, 2017 Category: General Medicine Source Type: news

ASTRO bestows grants to survivor groups
The American Society for Radiation Oncology (ASTRO) has named two recipients...Read more on AuntMinnie.comRelated Reading: ASTRO names Gold Medal winners ASTRO publishes new guideline for SBRT in lung cancer ASTRO releases oropharyngeal cancer guidelines ASTRO partners with ASCO's CancerLinQ ASTRO updates guidelines on painful bone metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2017 Category: Radiology Source Type: news

HPV Vaccination Prevents Cancers in Men, Too
For years, scientists have touted the HPV vaccination ’s power to reduce cervical cancer in women. Now, during Men’s Health Week, Texas physicians urge men to get vaccinated against HPV to prevent cancers. HPV causes several cancers in men and women, including oropharyngeal (cancers of the head and neck such as the throat and mouth), penile, anal, cervical and vaginal. Some cases are fatal. (Source: TMA News Room)
Source: TMA News Room - June 14, 2017 Category: Consumer Health News Source Type: news

ASTRO publishes new guideline for SBRT in lung cancer
The American Society for Radiation Oncology (ASTRO) has released a new clinical...Read more on AuntMinnie.comRelated Reading: Societies release guideline for localized prostate cancer ASTRO releases oropharyngeal cancer guidelines ASTRO partners with ASCO's CancerLinQ ASTRO updates guidelines on painful bone metastases Elekta to support ASTRO safety initiative (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 13, 2017 Category: Radiology Source Type: news

Hitachi and MD Anderson to investigate IMPT versus IMRT for oropharyngeal cancer
Japanese-based Hitachi's subsidiary Hitachi Healthcare Americas has signed an agreement to collaborate with the University of Texas MD Anderson Cancer Centre to evaluate the intensity-modulated proton beam therapy (IMPT) in a clinical trial for oroph … (Source: Drug Development Technology)
Source: Drug Development Technology - June 8, 2017 Category: Pharmaceuticals Source Type: news

MD Anderson and Hitachi to collaborate in research for treatment of oropharyngeal cancer of the head and neck
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Hitachi Healthcare Americas Corporation, have today announced that they have entered into an agreement to collaborate on research for a unique randomized clinical trial comparing the outcomes and side-effects of intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of oropharyngeal cancer of the head and neck. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2017 Category: International Medicine & Public Health Source Type: news

Large Study Shows Reduced Oral HPV Infections With Vaccine Large Study Shows Reduced Oral HPV Infections With Vaccine
Rates of oral HPV infection were reduced in young adults who had been vaccinated, suggesting protection from oropharyngeal cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Head and Neck Cancer Patients Need Coordinated Survivorship Care Planning
Improving oropharyngeal cancer survival rates necessitates better coordination of survivorship care between oncology teams and primary care providers, according to a presentation at ONS. (Source: CancerNetwork)
Source: CancerNetwork - May 6, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Head & Neck Cancer News Conferences/ONS 2017 Source Type: news

New ASTRO Guidelines for Oropharyngeal Cancer
In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 27, 2017 Category: Cancer & Oncology Authors: David Sher, MD Tags: Head & Neck Cancer Radiation Oncology Source Type: news

Management of Oropharyngeal Cancer in the HPV Era Management of Oropharyngeal Cancer in the HPV Era
The incidence of head and neck cancer associated with HPV has increased at an epidemic rate. Review prevention and management strategies here.Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

ASTRO Releases First Guidelines for Oropharyngeal Cancer ASTRO Releases First Guidelines for Oropharyngeal Cancer
ASTRO releases its first guidelines for the management of oropharyngeal cancer but purposefully avoids distinguishing between HPV-positive and -negative disease despite differences in prognosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Immunovaccine starts dosing in Phase Ib/II trial of DPX-E7 to treat HPV-related cancers
Canadian-based biopharmaceutical company Immunovaccine has started dosing patients in a Phase Ib/II trial of its vaccine DPX-E7 for the treatment of incurable human papillomavirus (HPV) related oropharyngeal, cervical and anal cancers. (Source: Drug Development Technology)
Source: Drug Development Technology - April 18, 2017 Category: Pharmaceuticals Source Type: news

ASTRO Guideline for Oropharyngeal Cancer Reflects Changes (CME/CE)
(MedPage Today) -- Less aggressive treatment for less aggressive disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 18, 2017 Category: Hematology Source Type: news

ASTRO releases oropharyngeal cancer guidelines
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline...Read more on AuntMinnie.comRelated Reading: ASTRO partners with ASCO's CancerLinQ ASTRO updates guidelines on painful bone metastases Elekta to support ASTRO safety initiative ASTRO releases updated APBI guide ASTRO: PET predicts outcomes in vulvar cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2017 Category: Radiology Source Type: news

New ASTRO Guideline Establishes Standard of Care for Curative Treatment of Oropharyngeal Cancer with Radiation Therapy
ARLINGTON, Va., April 17, 2017 -- (Healthcare Sales & Marketing Network) -- The American Society for Radiation Oncology (ASTRO) today issued a new clinical guideline for the management of oropharyngeal cancer. The guideline, "Radiation therapy for or... Devices, Oncology American Society for Radiation Oncology, radiotherapy, oropharyngeal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2017 Category: Pharmaceuticals Source Type: news

Guideline sets standard of care for treatment of oropharynx cancer with radiation therapy
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) today issued a new clinical guideline for the management of oropharyngeal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2017 Category: Cancer & Oncology Source Type: news

Robotic Surgery Thrifty Option in Oropharyngeal Cancer Robotic Surgery Thrifty Option in Oropharyngeal Cancer
Treatment of oropharyngeal cancer with transoral robotic surgery (TORS) may offer advantages over traditional approaches, researchers say.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Survival Worse in Patients With Rare Oropharyngeal Small-Cell Carcinoma
Oropharyngeal small-cell carcinoma was more likely to present as distant disease and was associated with worse survival outcomes compared with squamous cell carcinoma, according to new research. (Source: CancerNetwork)
Source: CancerNetwork - April 8, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Head & Neck Cancer News Source Type: news

A biomarker for cancer of the oropharynx
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) A growing number of cases of oropharyngeal cancer are considered to be a consequence of infection with human papillomaviruses (HPV). Scientists at the German Cancer Research Center (DKFZ) have now revealed that a single blood sample test for specific antibodies can identify persons who are at a high risk of developing this type of cancer ten years or more before cancer diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 3, 2017 Category: Cancer & Oncology Source Type: news

Ohio State joins national call for HPV vaccination as a means of preventing cancer
(Ohio State University Wexner Medical Center) Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers, vaccination rates remain low across the US, with just 41.9 percent of girls and 28.1 percent of boys completing the recommend vaccine series. papillomavirus (HPV). The nation's National Cancer Institute-designated cancer centers have joined together to issue a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 11, 2017 Category: Cancer & Oncology Source Type: news

Reducing radiation successfully treats HPV-positive oropharynx cancers and minimizes side effects
Human papillomavirus-positive oropharynx cancers (cancers of the tonsils and back of the throat) are on rise. After radiation treatment, patients often experience severe, lifelong swallowing, eating, and nutritional issues. However, new clinical trial research shows reducing radiation for some patients with HPV-associated oropharyngeal squamous cell carcinomas can maintain high cure rates while sparing some of these late toxicities. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 27, 2016 Category: Science Source Type: news

Predicting throat cancer recurrence with a blood test
Researchers found that patients whose oropharyngeal cancer recurred had higher levels of antibodies for two proteins, E6 and E7, which are found in HPV-fueled cancers. The finding suggests a potential blood-based marker that could predict when cancer is likely to return. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 15, 2016 Category: Science Source Type: news

Predicting throat cancer recurrence with a blood test
(University of Michigan Health System) Researchers found that patients whose oropharyngeal cancer recurred had higher levels of antibodies for two proteins, E6 and E7, which are found in HPV-fueled cancers. The finding suggests a potential blood-based marker that could predict when cancer is likely to return. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 15, 2016 Category: Global & Universal Source Type: news

IMRT associated with reduction in patient reported xerostomia
(NRG Oncology) A pooled analysis of data from NRG Oncology studies RTOG 0129 and 0522 compared intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy for patients treated for locally advanced head and neck squamous cell carcinoma. The study found that IMRT was associated with significantly reduced xerostomia and feeding tube dependency after treatment, especially in oropharyngeal cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news

Particular HPV strain linked to improved prognosis for throat cancer
(UNC Lineberger Comprehensive Cancer Center) In an analysis of survival data for a population of patients with a particular type of head and neck cancer, UNC Lineberger Comprehensive Cancer Center researchers confirmed that a particular strain of HPV, a virus linked to multiple cancers, resulted in better overall survival for patients with oropharyngeal cancer than patients with other strains of the virus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 3, 2016 Category: Global & Universal Source Type: news

Chronic Sinusitis Linked to Head and Neck Cancers in Elderly
Chronic sinusitis is associated with three rare types of head and neck cancer, including nasopharyngeal cancer, HPV-related oropharyngeal cancer, and nasal cavity and paranasal sinus cancers. (Source: CancerNetwork)
Source: CancerNetwork - September 10, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Head & Neck Cancer News Source Type: news

FDA Approves Keytruda (Pembrolizumab) for Head and Neck Cancer
By Stacy SimonThe US Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) to treat people with head and neck squamous cell carcinoma that has spread or come back after previous chemotherapy treatment. It’s the first immunotherapy drug approved for head and neck cancer. Keytruda is already approved for melanoma and non-small cell lung cancer.The FDA based its approval on a clinical trial of 174 people with head and neck squamous cell carcinoma that had spread or come back after they were treated with platinum-based chemotherapy. Tumors shrank or disappeared in 16% of the participants who were given...
Source: American Cancer Society :: News and Features - August 9, 2016 Category: Cancer & Oncology Tags: Oral Cavity and Oropharyngeal Cancer Source Type: news

Alcohol 'a direct cause of seven types of cancer'
Conclusion This narrative review aimed to summarise data from published biological and epidemiological research to discuss the strength of evidence that alcohol causes cancer. The author gives their main finding as a link between alcohol consumption and cancer at seven sites, and also that the highest risks seem to be associated with heavier drinking. However, they state there's no "safe" drinking threshold and that low to moderate consumption still contributes to a significant number of cancer cases. The biggest limitation of this review is that it doesn't appear to be systematic. The author provided no method...
Source: NHS News Feed - July 22, 2016 Category: Consumer Health News Tags: Cancer Lifestyle/exercise Source Type: news

New review concludes that evidence for alcohol causing cancer is strong
A new review of epidemiological evidence supports a causal association between alcohol consumption and cancers at seven sites in the body: oropharynx, larynx, esophagus, liver, colon, rectum and female breast. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 21, 2016 Category: Science Source Type: news

New review concludes that evidence for alcohol causing cancer is strong
( Society for the Study of Addiction ) A new review of epidemiological evidence supports a causal association between alcohol consumption and cancers at seven sites in the body: oropharynx, larynx, esophagus, liver, colon, rectum and female breast. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 21, 2016 Category: Global & Universal Source Type: news

American Cancer Society Updates HPV Vaccine Recommendations to Include Males
By Stacy Simon The American Cancer Society has updated its guideline for human papilloma virus (HPV) vaccination to include males. The change makes the guideline largely consistent with US government recommendations. The Advisory Committee on Immunization Practices (ACIP), part of the US Centers for Disease Control and Prevention (CDC), is the main source for US immunization policy. HPV VACCINE RESOURCES: Facts and Fears Recommendations by Age Detailed Information Almost everyone who is not vaccinated will get HPV at some time in their lives, and most will never know it. HPV is transmitted through sexual contact. The...
Source: American Cancer Society :: News and Features - July 19, 2016 Category: Cancer & Oncology Tags: Prevention/Early Detection Cervical Cancer Oral Cavity and Oropharyngeal Cancer Source Type: news

HPV-Associated Cancers on Rise in USHPV-Associated Cancers on Rise in US
Human papillomavirus-associated cancers include, most notably, those of the cervix and oropharynx. The majority of these cancers are attributable to the virus. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 7, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Fewer Gastrostomies After TORS Than After Chemo In Patients With Oropharyngeal CancerFewer Gastrostomies After TORS Than After Chemo In Patients With Oropharyngeal Cancer
Gastrostomy rates in patients with oropharyngeal cancer are significantly lower after transoral robotic surgery (TORS) than after chemoradiotherapy in the short term, according to a new study. Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 5, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news

SNMMI: PET/CT may help guide prostate biopsies
A new PET/CT imaging technique may be useful for guiding prostate biopsies...Read more on AuntMinnie.comRelated Reading: SNMMI: PET/CT uncovers adaptations in alcoholic brain Ga-68-based PET/CT good for neuroendocrine tumors PET/CT links stress with heart trouble PET/CT after therapy avoids surgery for head, neck cancer 3-month PET/CT helps track oropharyngeal cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 16, 2016 Category: Radiology Source Type: news

Oropharyngeal Cancer, Extracapsular Spread, and HPV p16 StatusOropharyngeal Cancer, Extracapsular Spread, and HPV p16 Status
Spread beyond the lymph nodes of oropharyngeal cancer and carcinoma of unknown primary site (CUP) is associated with greater recurrence and poorer survival in patients with human papillomavirus (HPV) p16-negative tumors, but not in those with p16-positive tumors. Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 31, 2016 Category: Pathology Tags: Hematology-Oncology News Source Type: news

To Predict and to Intercept
Disease interception – as opposed to the treatment of disease when it is diagnosed – has the potential to do two major things: to make things a great deal cheaper for cash-strapped health authorities and to offer patients a far better quality of life. In February 2015, Janssen launched its Disease Interception Accelerator (DIA), an ambitious platform which seeks to shift healthcare from diagnosis and treatment to prediction and pre-emption. In Janssen’s ideal world, the term ‘patient’ will become redundant, as intervening and stopping disease from progressing in healthy individuals becomes the...
Source: EyeForPharma - May 10, 2016 Category: Pharmaceuticals Authors: Adam Hill Source Type: news

Why You Should Pay Attention to Oral, Head and Neck Cancer Awareness Week -- April 10-16
Some may think another cancer awareness week is like Hallmark's Friendship Day -- nice, but not necessary. National Oral, Head, and Neck Cancer Awareness Week will take place April 10-16, 2016, and it's more important than ever because there actually is a big lack of awareness. Did you know that HPV-related throat cancer is on the rise at an alarming rate? According to the National Cancer Institute, the three most common cancers are breast, lung, and prostate cancer. But there will be an estimated 61,000 oral and throat cancer cases in 2016; an estimated 13,000 cases will result in death. Of those, some 9,000 people ar...
Source: Healthy Living - The Huffington Post - April 11, 2016 Category: Consumer Health News Source Type: news

PET/CT after therapy avoids surgery for head, neck cancer
Using PET/CT scans to assess response to therapy can help patients with head...Read more on AuntMinnie.comRelated Reading: 3-month PET/CT helps track oropharyngeal cancer Interrupted radiation therapy risks cancer recurrence PET/CT details hint at survival of head and neck cancer patients Oral HPV infection increasing in young men PET/CT prevents dissections for head and neck cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 24, 2016 Category: Radiology Source Type: news

ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer
By Stacy Simon The American Cancer Society has released a new Head and Neck Survivorship Care Guideline to help survivors of head and neck cancer and their primary care providers better manage their long-term care. The guideline addresses cancers of the oral cavity, tongue, lip, pharynx (throat), and larynx (voice box). Recommendations in the guideline may also apply to cancers of the salivary glands, nasal and paranasal sinuses, and nasopharynx. But it does not address cancers of the brain, thyroid, or esophagus because they are very different in terms of symptoms and treatment. RESOURCES: Head and Neck Cancer Survivor...
Source: American Cancer Society :: News and Features - March 23, 2016 Category: Cancer & Oncology Tags: Oral Cavity and Oropharyngeal Cancer Laryngeal and Hypopharyngeal Cancer Salivary Gland Cancer Nasal Cavity and Paranasal Sinus Cancer Nasopharyngeal Cancer Source Type: news